Mr. Chandrasekhar (Nat) Natarajan is the Chief Scientific Officer at ViNa Pharma
Consulting, LLC. He is also an Adjunct Faculty at Tufts School of Medicine. Earlier at
Sanofi as an Associate Vice President in Drug Disposition division and a Strategic
Scientific Advisor, supported Oncology programs providing critical input on translational pharmacology, ADME and PK/PD in discovery and development.
Nat received his B. Pharm and his MSc in Pharmacology from the University of Madras, India. His MS in Pharmacotherapeutics was from Long Island University, New York and his clinical pharmacy training was at Down State Medical Center in New York.
Nat has had years of experience in different areas of research at different levels at
Boehringer Ingelheim, Bristol Myers Squibb and Aventis. He was the Deputy Global
Head of Discovery MPK providing Discovery Support at Sanofi-Aventis overseeing
effective chemical optimization and druggability of new compounds for desirable ADME & pharmacokinetic properties.
Nat is an invited speaker (faculty) at, The Harvard Clinical and Translational Science
Center, Boston, MA, and Tufts Center for the Study of Drug Development, Tufts
University school of Medicine, Boston, MA. He has given presentations on Translational medicine at CSIR-Institute of Genomics & Integrative Biology (CSIR-IGIB), Mathura Road, New Delhi 110020, India., Gulf Medical
University, Ajman, United Arab Emirates., Cancer Drug Discovery & Preclinical
Development. Active Communications International, London, UK., Society for the Study of Xenobiotics-India, Bangalore, (SSX-India), and PERI, Biologics and Biosimilars, An Integrated Overview of Product Development, Fairfax, VA. Nat is an active member of AAPS, ACCP, SITC and DIA.
Copyright © 2021 PharmaPro Consulting Inc. - All Rights Reserved.